Bristol Myers Squibb gets FDA approval for metastatic melanoma therapy

Bristol Myers Squibb’s Opdualag is indicated to treat unresectable or metastatic melanoma in adult and paediatric patients. Credit: Bristol-Myers Squibb Company.